New devices enabling freely selectable dosing of solid oral medications are urgently needed for personalized medicine. One approach is the use of the recently published Solid Dosage Pen, allowing flexible dosing of tablet-like sustained release slices from drug loaded extruded strands. Slices were suitable for oral single dosed application. The aim of the present study was the development of immediate release dosage forms for applications of the device, especially for young children. Using two model drugs, two different concepts were investigated and evaluated. Effervescent formulations were manufactured by an organic wet-extrusion process and immediate release formulations by a melt-extrusion process. Dissolution experiments were performed for both formulations to ensure the immediate release behavior. Extruded strands were individually dosed by the Solid Dosage Pen. Various doses of the two formulations were analyzed regarding uniformity of mass and content according to pharmacopoeial specifications. Proof of concept was demonstrated in both approaches as results comply with the regulatory requirements. Furthermore, storing stress tests were performed and drug formulations were characterized after storing. The results show that suitable packaging material has been selected and storage stability is probable.
References
[1]
Stehle, S.; Kirchheiner, J.; Lazar, A.; Fuhr, U. Pharmacogenetics of oral anticoagulants-A basis for dose individualization. Clin. Pharmacokinet. 2008, 47, 565–594, doi:10.2165/00003088-200847090-00002.
[2]
Cholerton, S.; Daly, A.K.; Idle, J.R. The role of individual human cytochromes-P450 in drug-metabolism and clinical-response. Trends Pharmacol. Sci. 1992, 13, 434–439, doi:10.1016/0165-6147(92)90140-2.
[3]
Ingelman-Sundberg, M.; Sim, S.C.; Gomez, A.; Rodriguez-Antona, C. Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacol. Ther. 2007, 116, 496–526, doi:10.1016/j.pharmthera.2007.09.004.
[4]
Zhou, S.F.; Di, Y.M.; Chan, E.; Du, Y.M.; Chow, V.D.W.; Xue, C.C.L.; Lai, X.S.; Wang, J.C.; Li, C.G.; Tian, M.; et al. Clinical Pharmacogenetics and Potential Application in Personalized Medicine. Curr. Drug Metab. 2008, 9, 738–784, doi:10.2174/138920008786049302.
[5]
Kearns, G.L.; Abdel-Rahman, S.M.; Alander, S.W.; Blowey, D.L.; Leeder, J.S.; Kauffman, R.E. Developmental pharmacology-Drug disposition, action, and therapy in infants and children. N. Engl. J. Med. 2003, 349, 1157–1167, doi:10.1056/NEJMra035092.
[6]
Standing, J.F.; Tuleu, C. Paediatric formulations-Getting to the heart of the problem. Int. J. Pharm. 2005, 300, 56–66, doi:10.1016/j.ijpharm.2005.05.006.
[7]
Breitkreutz, J.; Boos, J. Paediatric and geriatric drug delivery. Expert Opin. Drug Deliv. 2007, 4, 37–45, doi:10.1517/17425247.4.1.37.
[8]
Stegemann, S.; Ecker, F.; Maio, M.; Kraahs, P.; Wohlfart, R.; Breitkreutz, J.; Zimmer, A.; Bar-Shalom, D.; Hettrich, P.; Broegmann, B. Geriatric drug therapy: Neglecting the inevitable majority. Ageing Res. Rev. 2010, 9, 384–398, doi:10.1016/j.arr.2010.04.005.
[9]
Wening, K.; Breitkreutz, J. Oral drug delivery in personalized medicine: Unmet needs and novel approaches. Int. J. Pharm. 2011, 404, 1–9, doi:10.1016/j.ijpharm.2010.11.001.
[10]
Stoltenberg, I.; Winzenburg, G.; Breitkreutz, J. Solid oral dosage forms for children- Formulations, excipients and acceptance issues. J. Appl. Ther. Res. 2010, 7, 141–146.
[11]
Walsh, J.; Bickmann, D.; Breitkreutz, J.; Chariot-Goulet, M. Delivery devices for the administration of paediatric formulations: Overview of current practice, challenges and recent developments. Int. J. Pharm. 2011, 415, 221–231, doi:10.1016/j.ijpharm.2011.05.048.
[12]
Breitkreutz, J.; Wessel, T.; Boos, J. Dosage Forms for Peroral Drug Administration to Children. Paediatr. Perinat. Drug Ther. 1999, 3, 25–33.
[13]
van Santen, E.; Barends, D.M.; Frijlink, H.W. Breaking of scored tablets: A review. Eur. J. Pharm. Biopharm. 2002, 53, 139–145, doi:10.1016/S0939-6411(01)00228-4.
[14]
Schoemakers, J.; Grummel, A. Dosing Stick Containing Rod-Shaped Tablets. WO 02/102296 A102291 2002.
[15]
Wening, K.; Breitkreutz, J. Novel delivery device for monolithical solid oral dosage forms for personalized medicine. Int. J. Pharm. 2010, 395, 174–181, doi:10.1016/j.ijpharm.2010.05.036.
[16]
Frobel, A.K. Untersuchung der Pharmakokinetik von Bisoprolol bei Kindern in einer klinischen Studie und mit physiologiebasierter Simulation als Konsequenz aus einem systematischen Cochrane-Review und als Beitrag zur Optimierung zukünftiger Studien (in German). Ph.D. Thesis, University of Duesseldorf, Duesseldorf, Germany, 2010.
[17]
Laer, S.; Mir, T.S.; Behn, F.; Eiselt, M.; Scholz, H.; Venzke, A.; Meibohm, B.; Weil, J. Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters. Am. Heart J. 2002, 143, 916–922, doi:10.1067/mhj.2002.121265.
[18]
Hermes, M.; Barnscheid, L.; Garsuch, V.; Schoettler, P.; Dominguez-Hirschi, J.; Breitkreutz, J. Arzneimittelversorgung von Kindern: Ergebnisse einer Studie zur praktischen Auswirkung der EU-Verordnung 1901/2006 "Better Medicines for children" seit ihrem Inkrafttreten im Januar 2007 (in German); [Drug prescription for children: Results of a study on the practical effect of the EU regulation No. 1901/2006 "Better medicines for children" since its coming into effect in January 2007]. Pharm. Ind. 2010, 72, 1334–1344.
[19]
European Medicines Agency (EMA). Formulations of Choice for the Paediatric Population: Reflection Paper. London, UK, 2006.
[20]
Lindberg, N.O.; Myrenas, M.; Tufvesson, C.; Olbjer, L. Extrusion of an effervescent granulation with a twin screw extruder, Baker Perkins MPF 50D-Determination of mean residence time. Drug Dev. Ind. Pharm. 1988, 14, 649–655, doi:10.3109/03639048809151891.
[21]
Kircher, W. Arzneiformen richtig anwenden,ergonomische Aspekte (in German). [Correct Use of Dosage Forms,Ergonomic Aspects]; Deutscher Apothekerverlag Stuttgart: Stuttgart, Germany, 2007; pp. 17–29.
[22]
Garsuch, V.; Breitkreutz, J. Novel analytical methods for the characterization of oral wafers. Eur. J. Pharm. Biopharm. 2009, 73, 195–201, doi:10.1016/j.ejpb.2009.05.010.
[23]
Dubey, R.; Jamalapuram, S. Development of intravenously injectable solution of carvedilol using a combination of pH adjustment and micellization. Eur. J. Parenter. Pharm. Sci. 2010, 15, 47–52.
[24]
Thommes, M.; Baert, L.; Rosier, J. 800 mg Darunavir tablets prepared by hot melt extrusion. Pharm. Dev. Technol. 2011, 16, 645–650, doi:10.3109/10837450.2010.508077.
